Published in EMBO Molecular Medicine · View the paper (DOI)
Scientists have engineered red blood cell lines to express fewer antigens, making them less immunogenic for patients with rare blood types. This breakthrough could lead to the development of more universal blood sources for transfusion patients.
Coverage from 2 institutions
- Tailoring blood cells in the laboratory EMBO · Apr 26, 2018 · first to report
- Bristol researchers use gene editing to improve red blood cell transfusion compatibility University of Bristol · Apr 27, 2018